Ardelyx reported $-32.79M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Amgen USD 4.61B 777M Jun/2026
Ardelyx USD -32.79M 37.89M Mar/2026
aTyr Pharma USD -128K 24.6M Mar/2026
Corcept Therapeutics USD 41.3M 90.9M Jun/2026
Curis USD -11.52M 3.64M Mar/2026
Sanofi EUR 2.27B 771M Mar/2026
TG Therapeutics USD 21.67M 13.12M Jun/2026
United Therapeutics USD 330.8M 5M Jun/2026